证券代码：002248 证券简称：华东数控 公告编号：2023-024 威海华东数控股份有限公司 同一股份只能选择现场投票、网络投票的一种表决方式。网络投票包含证券 交易系统和互联网系统两种投票方式，同一股份只能选择其中一种方式。同一表 决权出现重复表决的以第三次投票结果为准。 更正后： 一、本次会议的基本情况 2、网络投票：公司将通过深圳证券交易所交易系统和股东大会网络投票系统 平台（http://wltp.cninfo.com.cn）向全体股东提供网络形式的投票平台，股东可以 在网络投票时间内通过上述系统行使表决权。 1 关于召开2023年度第一次临时股东大会通知的更正公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 威海华东数控股份有限公司（简称"公司"）于2023年12月14日在巨潮资讯网 （http://www.cninfo.com.cn）、《中国证券报》、《证券日报》和《证券时报》披 露了《关于召开2023年度第一次临时股东大会的通知》（公告编号：2023-023）。 经事后审核发现，因工作人员疏忽，上述公告相关内容有误，现予以更正，具体 情况 ...

二〇二三年十二月十三日 1 本次处置闲置资产事项，有利于促进公司产品优化调整和转型升级，不存在 损害公司和股东权益的情况。本次资产处置不涉及关联交易，不构成《上市公司 重大资产重组管理办法》规定的重大资产重组。公司董事会审议、表决程序合法 合规。同意公司处置相关闲置资产。 独立董事：姜爱丽、石贵泉、包敦安 威海华东数控股份有限公司 独立董事关于处置闲置资产的独立意见 作为威海华东数控股份有限公司（以下简称"公司"）的独立董事，我们根据 《上市公司独立董事规则》、《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》等法律法规及《公司章程》、《独立董事工作规则》等的 有关规定，基于独立判断立场，对公司处置闲置资产事项发表独立意见如下： ...

本资产评估报告依据中国资产评估准则编制 威海华东数控股份有限公司拟资产处置 所涉及威海华东数控股份有限公司 部分资产市场价值 资产评估报告 鲁正信评报字(2023)第Z130号 (本报告共一册,本册为第一册 山东正源和信资产评估有限公司 二〇二三年十二月十二日 地址：济南市历下区经十路 13777 号中润世纪广场 18 号 14 层 邮编: 250001 电话: 0531-81666296 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 3737020001202300530 | | --- | --- | | 合同编号: | 鲁正信评合字(2023)第Z130号 | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 鲁正信评报字(2023)第2130号 | | 报告名称: | 威海华东数控股份有限公司拟资产处置所涉及威海 华东数控股份有限公司部分资产市场价值资产评估 报告 | | 评估结论: | 14,820,000.00元 | | 评估报告日: | 2023年12月12日 | | 评估机构名称: | 山东正源和信资产评估有限公司 | | 签名人员: | (资产评估师) ...

威海华东数控股份有限公司 第六届监事会第十四次会议决议公告 证券代码：002248 证券简称：华东数控 公告编号：2023-021 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 1、审议通过《关于处置闲置资产的议案》。 表决结果：3票同意，0票反对，0票弃权，同意票数占出席本次会议有表决权 票数的100%。 具体内容详见刊载于巨潮资讯网（http://www.cninfo.com.cn）、《证券时报》、《证 券日报》和《中国证券报》的《关于处置闲置资产的公告》（公告编号：2023-022）。 三、备查文件 一、监事会会议召开情况 威海华东数控股份有限公司（简称"公司"）第六届监事会第十四次会议（简称 "本次会议"）通知以电话、邮件等方式发出，会议于2023年12月13日上午9时30分 在公司会议室召开。会议由监事会主席宋大鹏主持，应出席监事3人，实际出席监 事3人，本次会议的召集召开符合有关法律、法规及《公司章程》的有关规定，会 议程序合法有效。 二、监事会会议审议情况 经与会监事表决，形成如下决议： 1、威海华东数控股份有限公司第六届监事会第十四次会议决议 ...

证券代码：002248 证券简称：华东数控 公告编号：2023-020 威海华东数控股份有限公司 第六届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 威海华东数控股份有限公司（简称"公司"）第六届董事会第十五次会议（简称 "本次会议"）通知以电话、邮件等方式发出，会议于2023年12月13日上午9时以现 场与通讯相结合方式在公司会议室召开。会议由董事长连小明主持，应出席董事8 人，实际出席董事8人，本次会议的召集召开符合有关法律、法规及《公司章程》 的有关规定，会议程序合法有效。 二、董事会会议审议情况 经与会董事表决，形成如下决议： 1、审议通过《关于处置闲置资产的议案》； 表决结果为：8 票同意，0 票反对，0 票弃权，同意票数占出席本次会议有表 决权票数的 100%。 独立董事发表了同意的独立意见，具体内容详见刊载于巨潮资讯网 （http://www.cninfo.com.cn）的《独立董事关于处置闲置资产的独立意见》。 具体内容详见刊载于巨潮资讯网（http://www.cninfo.com.cn） ...

威海华东数控股份有限公司 证券代码：002248 证券简称：华东数控 公告编号：2023-022 关于处置闲置资产的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、交易概述 本次拟处置的资产包括闲置设备共计2台及库存产品、原材料，均已使用或存 放多年，设备精度、生产效率等难以满足公司目前生产需要或不具备继续使用条 件，不符合公司产品升级战略要求。本次拟处置的资产已经山东正源和信资产评 估有限公司以2023年12月5日为评估基准日进行评估，账面价值5,378.20万元，评 估市场价值1,482.00万元。具体情况如下： 威海华东数控股份有限公司（简称"公司"）第六届董事会第十五次会议审议通 过了《关于处置闲置资产的议案》，为适应公司产品优化调整和转型升级的需要， 回笼资金，引进先进生产设备，提升产品精度和质量，公司拟处置部分闲置资产。 独立董事发表了同意的独立意见，具体内容详见2023年12月14日刊载于巨潮资讯 网的《独立董事关于处置闲置资产的独立意见》。本次交易尚需提交股东大会审议， 不构成关联交易，不构成《上市公司重大资产重组管理办法》规定的重大 ...

证券代码：002248 证券简称：华东数控 公告编号：2023-023 威海华东数控股份有限公司 关于召开2023年度第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 威海华东数控股份有限公司（简称"公司"）第六届董事会拟定于 2023 年 12 月 29 日（星期五）召开 2023 年度第一次临时股东大会（以下简称"本次会议"）， 会议有关事项如下： 一、本次会议的基本情况 （一）本次会议届次：2023年度第一次临时股东大会。 （二）本次会议召集人：公司第六届董事会。 （三）本次会议召开的合法、合规性：本次会议召开符合有关法律、行政法 规、部门规章、规范性文件和《公司章程》等的有关规定。 （四）本次会议召开日期、时间： 现场会议召开时间：2023年12月29日（星期五）下午2:00。 网络投票时间：2023年12月29日。其中，通过深交所交易系统进行网络投票 的具体时间为：2023年12月29日上午9:15至9:25、9:30至11:30，下午13:00至15:00； 通过深交所互联网投票的具体时间为：2023年12月29日上午9:1 ...

Financial Performance - The company's revenue for Q3 2023 was ¥74,821,808.99, representing a 21.72% increase year-over-year[3] - Net profit attributable to shareholders decreased by 56.36% to ¥1,441,080.03 in Q3 2023[3] - The net profit after deducting non-recurring gains and losses fell by 89.93% to ¥144,902.34[3] - Total operating revenue for the current period reached ¥226,460,671.06, an increase of 14.69% compared to ¥197,464,606.30 in the previous period[22] - Net profit attributable to shareholders of the parent company was ¥9,736,964.90, a decrease of 13.93% from ¥11,298,385.11 in the previous period[22] - The company reported a total profit of ¥9,605,476.18, down from ¥11,086,707.49 in the previous period[22] - Basic and diluted earnings per share decreased to ¥0.03 from ¥0.04 in the previous period[22] Cash Flow and Operating Activities - Cash flow from operating activities increased significantly by 298.29% to ¥30,945,736.42 year-to-date[3] - Operating cash flow net amount improved to ¥30,945,736.42, compared to a negative cash flow of ¥15,606,057.47 in the previous period[25] - Cash and cash equivalents at the end of the period totaled ¥40,955,254.77, up from ¥19,144,758.55 in the previous period[25] - The company received cash related to investment activities amounting to ¥37,700,000.00, compared to ¥23,000,000.00 in the previous period[25] Assets and Liabilities - Total assets at the end of Q3 2023 were ¥543,332,004.36, a decrease of 3.10% from the previous year[3] - The company's total assets as of September 30, 2023, amount to ¥543,332,004.36, a decrease from ¥560,740,396.04 at the beginning of the year[19] - Total current assets decreased from ¥440,493,573.77 to ¥425,377,752.43 during the same period[17] - Total liabilities decreased from ¥484,417,930.60 to ¥456,762,036.24[19] - The company's total equity as of September 30, 2023, is ¥86,569,968.12, up from ¥76,322,465.44 at the beginning of the year[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 76,558[11] - The largest shareholder, Weihai Weigao International Medical, holds 17.50% of shares, totaling 53,825,800 shares[11] Expenses - Financial expenses rose by 55.77% to ¥4,641,519.81 due to increased foreign exchange losses[8] - Research and development expenses were ¥7,358,731.81, slightly up from ¥7,202,158.32 in the previous period[22] - Financial expenses increased to ¥4,641,519.81, compared to ¥2,979,806.81 in the previous period, with interest expenses at ¥5,046,166.69[22] Inventory and Receivables - The company experienced a 150.88% increase in accounts receivable, reaching ¥24,565,666.70 at the end of the reporting period[9] - The accounts receivable increased significantly from ¥9,791,710.60 to ¥24,565,666.70[17] - The company's inventory decreased from ¥276,668,433.72 to ¥250,493,649.87[17] Other Information - The company reported a net loss of ¥1,028,210,594.05 in retained earnings as of September 30, 2023[19] - The weighted average return on equity was 1.67%, down by 2.79% compared to the previous year[3] - The company has not undergone an audit for the third quarter report[13] - The company reported a 324.63% increase in taxes and surcharges to ¥1,501,334.86 year-to-date[8] - Total operating costs increased to ¥216,230,571.23, up 15.98% from ¥186,403,184.96 in the previous period[22]

证券代码：002248 证券简称：华东数控 公告编号：2023-018 威海华东数控股份有限公司 关于重大仲裁的进展公告 大连机床系列企业每家普通债权人 30 万元以上部分，以通用技术集团大连机 床有限责任公司的 49%股权按照 20.55 元债权/股的价格进行以股抵债清偿； 重整计划经法院裁定批准后十日内，债权人应向大连机床系列企业和管理人 出具普通债权清偿方式等相关信息的书面确认函，如未在规定的期限内进行书面 1 确认的，视为接受以股抵债清偿。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、本次重大仲裁事项概述 威海华东数控股份有限公司（简称"公司"或"华东数控"）作为申请人由于证券 认购纠纷向北京仲裁委员会递交了仲裁申请书，大连高金科技发展有限公司（以 下简称"高金科技"）为本次仲裁被申请人。2021 年 10 月 15 日，公司收到北京仲 裁委员会送达的《关于（2021）京仲案字第 5677 号仲裁案受理通知》。2022 年 4 月，公司收到北京仲裁委员会送达的《裁决书》（2022）京仲裁字第 1223 号。具 体内容详见刊载于巨潮资讯网（htt ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥151,638,862.07, representing an increase of 11.50% compared to ¥135,993,765.05 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was ¥8,295,884.87, up 3.75% from ¥7,996,155.92 year-on-year[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 25.54%, reaching ¥6,801,467.55 compared to ¥5,417,967.35 in the previous year[23]. - The net cash flow from operating activities was ¥8,079,187.96, a significant increase of 883.23% from a negative cash flow of -¥1,031,518.83 in the same period last year[23]. - The company's gross profit margin in the machinery manufacturing sector was 22.50%, slightly up from 22.16% in the previous year[55]. - The company reported a significant increase in revenue from international markets, which rose by 79.74% to ¥24,739,906.39, compared to ¥13,764,195.43 in the previous year[53]. - The company reported a net loss of RMB 1,029,651,674.08 as of June 30, 2023, slightly improved from a loss of RMB 1,037,947,558.95 at the beginning of the year[126]. - The comprehensive income for the first half of 2023 was CNY 8,188,752.38, compared to CNY 7,822,278.96 in the same period of 2022, indicating an increase of about 4.7%[149]. Assets and Liabilities - Total assets at the end of the reporting period were ¥555,173,039.19, a decrease of 0.99% from ¥560,740,396.04 at the end of the previous year[23]. - The company's monetary funds at the end of the period were 26.22 million yuan, a decrease of 38.77% compared to the beginning of the year[43]. - Accounts receivable increased by 901.43 thousand yuan, representing a 92.06% increase compared to the beginning of the year[44]. - The company's total liabilities decreased from RMB 484,417,930.60 to RMB 470,351,575.95, reflecting a decline of about 2.14%[126]. - The company's equity attributable to shareholders increased from RMB 76,746,376.03 to RMB 85,352,506.32, an increase of approximately 11.67%[126]. Dividends and Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for the current year[15]. - The total number of ordinary shareholders at the end of the reporting period was 59,633[114]. - The largest shareholder, Weihai Weigao International Medical Investment Co., Ltd., holds 17.50% of the shares, totaling 53,825,800 shares[114]. Research and Development - The company specializes in the R&D, production, and sales of CNC machine tools and key functional components, with no significant changes in its main business since establishment[29]. - The company has obtained a total of 171 patents, including 32 invention patents and 136 utility model patents, showcasing its strong R&D capabilities[35]. - Research and development expenses for the first half of 2023 were ¥4,758,760.60, slightly up from ¥4,636,985.97 in the previous year[134]. Market and Competition - The company emphasizes the importance of market conditions and operational efforts in achieving its 2023 business targets, highlighting potential risks[14]. - The company faces intense competition in the machine tool market, particularly in the CNC machine tool segment, where competition is based on quality, price, and service[70]. - The company maintains a leading position in machine tool manufacturing with multiple domestic patents and proprietary technologies, and collaborates with renowned foreign enterprises and domestic research institutions[71]. Operational Efficiency - The company focuses on a business model that integrates technology research and development, product manufacturing, and external sales[33]. - The company’s CNC machine tools have a high degree of automation, with CNC machines accounting for 60% of all machine tools, significantly improving production efficiency by 3-7 times compared to traditional machines[39]. - The company has implemented measures to mitigate risks from raw material price fluctuations, including focusing on CNC machine tools and enhancing internal management[69]. Financial Management - The company has not distributed cash dividends or conducted capital reserve transfers in the first half of the year[77]. - The company did not engage in any related party transactions during the reporting period[93]. - The company has not experienced any major litigation or arbitration matters during the reporting period[90]. Future Outlook - The company is focused on expanding its product offerings and enhancing technological capabilities to meet the demands of precision machining in emerging industries[30]. - The strategic focus includes enhancing product quality and expanding market reach in sectors such as aerospace and new energy vehicles[30]. - The company continues to focus on technological advancements and market expansion strategies as part of its growth plan[157].